This communication reports that the TiO2@polydopamine nanocomposite with a core-shell structure could be a highly active photocatalyst working under visible light. A very thin layer of polydopamine at around 1 nm was found to be critical for the degradation of Rhodamine B.
No takes yet. Share an insight, caveat, or question.
Mao et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: